Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

10 Apr, 2018, 12:30 BST Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma

Once approved, this product could represent a significant milestone for patients with relapsing-remitting multiple sclerosis Mapi Pharma has...


10 Apr, 2018, 07:22 BST BerGenBio Completes Recruitment Into First Stage of Phase II NSCLC Trial With Selective AXL Inhibitor Bemcentinib Combined With KEYTRUDA®

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors as a potential cornerstone...


09 Apr, 2018, 15:00 BST SI-BONE, Inc. Announces Publication of 3-Year Long-term Prospective Outcomes Including Randomized Controlled Trial Data on 103 Patients Post SI Joint Fusion with Triangular iFuse Implant System®

Results include 57 Patients at 4 years showing continued durability SI-BONE, Inc., a medical device company that pioneered the minimally...


09 Apr, 2018, 08:30 BST Grünenthal and KU Leuven Join Forces to Develop an Innovative Non-Opioid Pain Treatment

Grünenthal, the Katholieke Universiteit Leuven's Centre for Drug Design and Discovery (CD3) and the Laboratory of Ion Channel Research (LICR)...


09 Apr, 2018, 08:30 BST Equashield And Transmedic Pte Ltd. Partner to Increase Safe Handling of Hazardous Drugs in Hong Kong; Expand Upon Successful CSTD Distribution Deal in Singapore

Distribution expansion marks shift to clinically-proven safety provisions for nurses and pharmacists in burgeoning Hong Kong market Equashield...


05 Apr, 2018, 19:10 BST "Transcriptional wiring" of cancer genes can be resolved using Lexogen's SLAMseq and QuantSeq technologies to facilitate drug discovery

Identifying molecules that selectively modulate gene expression is highly desirable in drug development. However, standard RNA sequencing...


05 Apr, 2018, 10:58 BST Oncoinvent Publishes Data Explaining Radspherin ® 's Mechanism of Action

Data describing and explaining Radspherin® 's mechanism of action has been published in the Journal of Labelled Compounds and...


04 Apr, 2018, 19:05 BST Regenerative Patch Technologies Announces Publication of Initial Results from Phase 1/2a Clinical Trial in Advanced Dry Age-Related Macular Degeneration

Preliminary Results from Initial Patients in the Clinical Trial Demonstrate Safe Delivery of the CPCB-RPE1 Implant and Positive Impact on Retinal...


04 Apr, 2018, 07:00 BST BERG Announces the Dosing of First UK Patient in Phase II Combination Trial of BPM 31510 and Gemcitabine for Patients with Pancreatic Cancer

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the dosing of the first...


03 Apr, 2018, 15:23 BST Nox Medical's Disposable Sleep Sensor Patent Survives Natus' Challenge in USA and Europe

Nox Medical, a leading sleep diagnostic medical device company and innovator has achieved a major success in EPO opposition proceedings initiated...


03 Apr, 2018, 11:36 BST Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes With AI

Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims in latest venture round....


03 Apr, 2018, 07:00 BST Multi-Center, Double-Blind Clinical Study Validates DefenAge® As A Best-In-Class Anti-Aging Solution, Naturally Turning Back The Clock

Breakthrough Peptide Reverses Signs Of Global Skin Aging In Six Weeks Progenitor Biologics®, LLC, the manufacturer and distributor of the...


29 Mar, 2018, 01:23 BST Commencement Of Phase II Clinical Study Of GDC-0084

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology drug development company, is pleased to announce commencement of an...


27 Mar, 2018, 12:30 BST Erasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy With the CyberKnife® System

New Clinical Trial Evaluates Use of Online-Adaptive Stereotactic Body Radiation Therapy Approach in the Treatment of Oligometastases Accuray...


27 Mar, 2018, 09:20 BST Clinical Trial Management System Market Worth $2.26 Billion By 2024: Grand View Research, Inc.

The global CTMS market is expected to reach USD 2.26 billion by 2024, according to a new report by Grand View Research, Inc. Rising research...


26 Mar, 2018, 15:03 BST The NASH Education Program™, Giving Voice to the "Silent Epidemic" Afflicting 25 Million Americans, Launches in the United States on March 26

- On March 26, The NASH Education Program™ launches in the United States to bring awareness to a little-known, asymptomatic disease...


26 Mar, 2018, 09:00 BST New Study Highlights the Use of MR-proADM in Assessing Disease Severity and Treatment Response in Patients with Sepsis and Septic Shock

Analysis shows the additional value of MR-proADM in formulating early escalation and de-escalation treatment strategies In collaboration...


26 Mar, 2018, 09:00 BST Pythagoras Medical Receives CE-Mark for the ConfidenHT™ System

Unique nerve mapping technology for renal denervation (RDN) procedure provides more effective treatment for resistant hypertension...


22 Mar, 2018, 07:27 GMT BerGenBio to Present Overview of Phase II Clinical Trial Portfolio Combining Bemcentinib With KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors as a potential cornerstone...


21 Mar, 2018, 12:14 GMT BioArctic Receives Regulatory Approval in Norway for a Clinical Study in Patients With Complete Spinal Cord Injury

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has received approval by the Norwegian Medicines Agency (NOMA)...


20 Mar, 2018, 11:00 GMT Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease

Ocugen, Inc., a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved...


20 Mar, 2018, 07:26 GMT Urgo Medical: The Clinical Trial EXPLORER is the First Study to Demonstrate the Efficacy of a Dressing (Urgostart®) in Diabetic Foot Ulcer Healing

A revolution in diabetic foot ulcer treatment and care Published in The Lancet Diabetes & Endocrinology, the EXPLORER [1] clinical trial...


19 Mar, 2018, 12:00 GMT Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity

Oral session #12 Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of...


19 Mar, 2018, 10:08 GMT Texas Cardiac Arrhythmia Institute at St. David's Medical Center draws cardiac experts from across the globe for EPLive 2018

On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its fourth international symposium on...